Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Clinical Biochemistry
|
December 10, 2014
PAPP-A and IGFBP-4 fragment levels in patients with ST-elevation myocardial infarction treated with heparin and PCI
Rikke Hjortebjerg, Søren Lindberg, Søren Hoffmann, et al.
European Journal of Preventive Cardiology
|
June 8, 2014
MR-proANP improves prediction of mortality and cardiovascular events in patients with STEMI
Søren Lindberg, Jan Skov Jensen, Sune H Pedersen, et al.
European Journal of Heart Failure
|
April 12, 2014
Cardio-adipose tissue cross-talk: relationship between adiponectin, plasma pro brain natriuretic peptide and incident heart failure
Søren Lindberg, Jan Skov Jensen, Mette Bjerre, et al.
American Heart Journal
|
November 10, 2012
Soluble form of membrane attack complex independently predicts mortality and cardiovascular events in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention
Søren Lindberg, Sune H Pedersen, Rasmus Mogelvang, et al.
European Journal of Preventive Cardiology
|
April 25, 2013
High osteopontin levels predict long-term outcome after STEMI and primary percutaneous coronary intervention
Mette Bjerre, Sune H Pedersen, Rasmus Møgelvang, et al.
Journal of the American Heart Association
|
March 19, 2017
Insulin-Like Growth Factor Binding Protein 4 Fragments Provide Incremental Prognostic Information on Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction
Rikke Hjortebjerg, Søren Lindberg, Sune Pedersen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 28, 2014
Plasma neutrophil gelatinase-associated lipocalinin in the general population: association with inflammation and prognosis
Søren Lindberg, Jan S Jensen, Rasmus Mogelvang, et al.
Journal of the American College of Cardiology
|
July 21, 2012
Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
Søren Lindberg, Sune H Pedersen, Rasmus Mogelvang, et al.
The American Journal of Cardiology
|
November 23, 2011
Usefulness of adiponectin as a predictor of all cause mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
Søren Lindberg, Sune H Pedersen, Rasmus Møgelvang, et al.
Diabetes Care
|
August 1, 2014
Low adiponectin levels and increased risk of type 2 diabetes in patients with myocardial infarction
Søren Lindberg, Jan S Jensen, Sune H Pedersen, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Clinical Biochemistry
|
December 10, 2014
PAPP-A and IGFBP-4 fragment levels in patients with ST-elevation myocardial infarction treated with heparin and PCI
Rikke Hjortebjerg, Søren Lindberg, Søren Hoffmann, et al.
European Journal of Preventive Cardiology
|
June 8, 2014
MR-proANP improves prediction of mortality and cardiovascular events in patients with STEMI
Søren Lindberg, Jan Skov Jensen, Sune H Pedersen, et al.
European Journal of Heart Failure
|
April 12, 2014
Cardio-adipose tissue cross-talk: relationship between adiponectin, plasma pro brain natriuretic peptide and incident heart failure
Søren Lindberg, Jan Skov Jensen, Mette Bjerre, et al.
American Heart Journal
|
November 10, 2012
Soluble form of membrane attack complex independently predicts mortality and cardiovascular events in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention
Søren Lindberg, Sune H Pedersen, Rasmus Mogelvang, et al.
European Journal of Preventive Cardiology
|
April 25, 2013
High osteopontin levels predict long-term outcome after STEMI and primary percutaneous coronary intervention
Mette Bjerre, Sune H Pedersen, Rasmus Møgelvang, et al.
Journal of the American Heart Association
|
March 19, 2017
Insulin-Like Growth Factor Binding Protein 4 Fragments Provide Incremental Prognostic Information on Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction
Rikke Hjortebjerg, Søren Lindberg, Sune Pedersen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 28, 2014
Plasma neutrophil gelatinase-associated lipocalinin in the general population: association with inflammation and prognosis
Søren Lindberg, Jan S Jensen, Rasmus Mogelvang, et al.
Journal of the American College of Cardiology
|
July 21, 2012
Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
Søren Lindberg, Sune H Pedersen, Rasmus Mogelvang, et al.
The American Journal of Cardiology
|
November 23, 2011
Usefulness of adiponectin as a predictor of all cause mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
Søren Lindberg, Sune H Pedersen, Rasmus Møgelvang, et al.
Diabetes Care
|
August 1, 2014
Low adiponectin levels and increased risk of type 2 diabetes in patients with myocardial infarction
Søren Lindberg, Jan S Jensen, Sune H Pedersen, et al.
Page
of 3